(NewsDirect)
McapMediaWire ---NuGene International, Inc./ Livento Group,Inc . (OTC: NUGN ), a dynamic group thatspecializes in acquiring and developing companies with disruptivebusiness models in film, content, and technology for fund managers,announced it has finalized the acquisition of Novel-Ti , a companyspecializing in Artificial Intelligence and Robotic IndustrySolutions.
About Novel-Ti
Novel-Ti was created in 2013 by two partners, anengineer in computer science and a PhD engineer who is qualified inelectrical engineering and fuzzy logic, which is an approach tovariable processing that allows for multiple possible truth values tobe processed through the same variable.
Novel-Ti has eight engineers and PhDengineers. It has developed many bespoke innovative applications,utilizing artificial intelligence and computer vision in differentsectors including the finance, automotive and healthcare sector. Wewill be releasing more information about the nature of some of thevery sophisticated programs developed by the company in the comingdays. The company’s clients have included major corporations andbusiness who are seeking unique solutions to solve complexproblems.
DavidStybr - Livento Group CEO - “The artificial intelligence marketequated to $50 billion USD in 2020 and is expected to reach $185billion USD in 2026. The Novel-Ti acquisition is just the start ofwhat investors and customers will see from the Livento AI &Robotics Solutions division. After completion of the acquisition andintegration of the Novel-Ti acquisition, we will focus on businessgrowth and harnessing the power of the team to add value across theLivento Business. Livento will remain opportunistic regarding furtheracquisitions within the industry. We forecast revenue of $1M USD in2023 from their existing clients and additional revenue from solutionsdeveloped by the team that are sold as solutions across the industry.An example of this is project ‘OWL’. OWL is a very excitingproject and the Novel-Ti Solution is transformational.
AboutOWL
AtLivento Group we couldn’t pass up this opportunity to acquire acompany that specializes in treating neurological disorders anddiseases that effects millions of people around the world. Theuncontrolled annual growth of neurodevelopmental and neurodegenerativepathologies requires an urgent solution. It’s estimated that Autismeffects 75 million people, Alzheimer’s effects 78 million people,and will cost society an estimated $2.8 Trillion USD by 2030.
To fight against thisdisease, Novel-Ti uses its expertise in Artificial Intelligence andimage processing. Novel-Ti has developed an interactive solution incollaboration with professionals in neurological pathologies. Theapplication identifies areas of brain, which require an activereconnection.
Thevisual analysis of the participants behaviour in real time allows thesystem to monitor and adapt each exercise individually, as well asanalysing the progress made at each session.
A unique hardwareand software solution
The second project in the pipeline for Novel-Ti isin the Robotics sector. The Livento team is in discussions with aproduction facility in the Czech Republic. The facility specializes inproducing robotics solutions, The Novel-Ti team is tasked to deliverprogramming works for two new automated robotic prototypes which willbe used in various business cases. Livento is in discussion to havelarger involvement in the projects. Livento will seek to achievehigher revenue potential in the Articifial Intelligence sector.
Mr Zied Loukil, founderof Novel-Ti, stated: “Livento plans to position the new division asa major player in the Artificial Intelligence industry, combining thestrengths of the Marketing and Commercial power of Livento and theexpertise of the Novel-Ti team, which will enable Novel-Ti to grow ourclient base and product lines increasing revenues and marketshare.”
The newdivision of Livento will be managed from our European offices and willbe led by Mr. Willem van der Meer, Mr. Olivier Somville and Mr. ZiedLoukil. The acquisition will be fully paid in Livento restrictedshares.
Safe Harbor Statement:
This release containsforward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. You can identify thesestatements as predictions, projections, or references future eventsand expectations, possibilities or similar. Forward-looking statementsinvolve risks and uncertainties that could cause results to differmaterially from those projected or anticipated. Although the Companybelieves the expectations reflected in our forward-looking statementsare based on reasonable assumptions, the Company is unable to give anyassurance that its expectations will be attained due to severalvariable factors. Factors or events that could cause actual results todiffer may emerge, and it is impossible for the Company to predict allof them. Some of these risks and uncertainties include, but are notlimited to, general economic and business conditions, effects ofcontinued geopolitical unrest and regional conflicts, in customerorder patterns, changes in consumer trends, and various other factorsbeyond the Company's control. Although the Company intends toprovide public updates, it undertakes no obligation to publicly updateany forward-looking statement, whether as a result of new information,future developments or otherwise, except as may be required bylaw.
Contact:
David Stybr, CEO
Livento Group, Inc.
Boxo Productions | | | Instagram |
ContactDetails
Livento Group, Inc.
Copyright (c) 2023 TheNewswire - All rights reserved.